Risedronate Sodium 59762-0405-04
- Manufacturer
- Mylan Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 17, 2002
- Listing Expires
- December 31, 2027
- Application
- NDA020835
Need to source Risedronate Sodium? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Risedronate Sodium Hemipentahydrate | 30.1 mg/1 |
| Risedronate Sodium Monohydrate | 4.9 mg/1 |
Drug Class
Bisphosphonate [EPC]Bisphosphonate [EPC]Diphosphonates [CS]
Selected Package
59762-0405-04Selected4 TABLET, FILM COATED in 1 DOSE PACK (59762-0405-4)